摘要
S-炔丙基半胱氨酸(S-propargyl-cysteine, SPRC)是通过对大蒜内含硫活性成分S-烯丙基半胱氨酸(SAC)结构修饰改造得到的新型内源性硫化氢(H2S)供体。研究发现,SPRC及其缓控释剂可以调控体内H2S水平,在多个心血管疾病模型中表现出良好的保护作用,可以通过发挥抗炎、抗氧化、抗纤维化等机制,起到保护心肌缺血、促进血管新生、稳定动脉粥样硬化斑块等作用。此外,SPRC在脑血管疾病、阿尔茨海默病、癌症、糖尿病肾病、子宫内膜异位症等疾病模型中也表现出良好的药理活性。本文通过文献查找和资料收集对SPRC药理作用研究进展进行综述,以期为SPRC的进一步研究提供参考。
S-propargyl-cysteine (SPRC) is a novel endogenous hydrogen sulfide (H2S) donor obtained by modi-fying the structure of the sulfur-containing active ingredient S-allylcysteine (SAC) in garlic. Studies have found that SPRC and its controlled-release formulations can regulate the level of H2S in vivo and have shown effective protective effects in multiple cardiovascular disease models. SPRC has exerted anti-inflammatory, anti-oxidation and anti-fibrosis effects to protect ischemic myocardium, promote angiogenesis, and to stabilize atherosclerotic plaque, etc. In addition, SPRC also has shown great pharmacological activity in other disease models such as cerebrovascular disease, Alzheimer’s disease, cancer, diabetic nephropathy, and endometriosis. This article reviews the current research progress on pharmacological effects of SPRC through literature search and data collection, aiming at providing the reference for the further research of SPRC.
出处
《药物资讯》
2021年第5期274-282,共9页
Pharmacy Information
